Laboratory research materials for in vitro use only.

$20 flat-rate shipping across Canada  ·  Free shipping on orders over $350

Selank

For laboratory research use only (in vitro). Not for human or animal use.

15% OFF Create an account and get 15% off your first order
Select Size — Price Per Vial

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$57.99Your price
3-4 units5% off$55.09Your price
5-9 units10% off$52.19Your price
10+ units Best Value15% off$49.29Your price

25% Pre-Order Discount Applied

The 25% pre-order discount is the maximum available and overrides volume pricing. There is no additional volume discount.

Pay via Interac e-Transfer

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

Interac e-Transfer

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence TKPRPGP
Molecular Weight 751.9 Da
Molecular Formula C33H57N11O9
CAS Number 129954-34-3
Purity ≥98% (HPLC)
Format Lyophilized Powder
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Approved

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

Selank is a synthetic heptapeptide with the molecular formula C33H57N11O9 and a molecular weight of 751.9 Da (CAS number 129954-34-3). The amino acid sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, consisting of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a stabilizing Pro-Gly-Pro extension at the C-terminus. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank is approved in Russia as an anxiolytic and nootropic compound.

The Pro-Gly-Pro extension serves dual purposes: it enhances metabolic stability by protecting against carboxypeptidase degradation, and this tripeptide sequence itself (glyproline) possesses independent neuromodulatory properties.

Property Value
Molecular Formula C33H57N11O9
Molecular Weight 751.9 Da
CAS Number 129954-34-3
Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro
Research Status Approved in Russia (anxiolytic/nootropic)

Research Overview

Selank has been investigated in clinical and preclinical research spanning anxiolytic effects, cognitive enhancement, immunomodulation, and gene expression regulation. The mechanism of action is multimodal: the tuftsin component activates phagocytic immune cells through the neuropilin-1 receptor and Fc receptor system, while the compound as a whole modulates monoamine neurotransmitter systems (serotonin, dopamine, norepinephrine) and influences the expression of neurotrophic factors including BDNF.

Selank has been shown to modulate the expression of over 50 genes involved in immune and inflammatory responses, suggesting a broad regulatory role at the transcriptional level.

Key areas of published research include:

  • Anxiolytic Effects: Clinical studies in Russia have demonstrated that Selank (administered intranasally) reduces anxiety symptoms comparable to benzodiazepines but without sedation, cognitive impairment, or dependence liability. This profile led to its approval as an anxiolytic in Russia.
  • Cognitive Enhancement: Research has shown improvements in learning, memory consolidation, and attention in both animal models and human studies, potentially mediated through BDNF upregulation and monoamine system modulation.
  • Immunomodulation: The tuftsin-derived component activates innate immune cells, and Selank has demonstrated immunomodulatory effects across multiple immune parameters in preclinical and clinical studies.

Selank is approved in Russia but not in North America or Europe. Clinical evidence is primarily from Russian-language publications.

Specifications

All Selank supplied by Prescott Bio Canada is manufactured to research-grade standards.

Specification Detail
Purity >98% (HPLC)
Form Lyophilized powder
Appearance White to off-white powder
Storage (lyophilized) -20°C, protected from light
Storage (reconstituted) 2-8°C, use within 30 days
Solubility Soluble in bacteriostatic water, sterile water, or normal saline

Each vial is accompanied by a Certificate of Analysis (COA) documenting purity, identity, and endotoxin testing.

Research Applications

Selank is supplied exclusively for in vitro and in vivo laboratory research. Published experimental applications include:

  • Anxiolytic mechanism research and GABA/serotonin system modulation studies
  • Cognitive enhancement and BDNF-mediated neuroplasticity research
  • Immunomodulation and tuftsin receptor pharmacology
  • Gene expression profiling and transcriptomic regulation studies
  • Monoamine neurotransmitter system modulation research

Researchers should consult the primary literature and institutional review protocols before designing experiments with Selank.

Storage and Handling

Lyophilized powder: Store at -20°C in the original sealed vial, protected from light and moisture. Under these conditions, Selank maintains stability for up to 24 months.

Reconstituted solution: Reconstitute with bacteriostatic water or sterile water. Store reconstituted Selank at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles.

Handling precautions: This product is intended for research use only (RUO). Not for human or veterinary diagnostic or therapeutic use. Handle using standard laboratory safety practices including appropriate PPE.

Additional information

Size

5mg, 10mg

Published Research

4 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

A New Generation of Drugs – Synthetic Peptides Based on Natural Regulatory Peptides

Kolomin TA, Shadrina MI, Slominsky PA, Limborska SA, Myasoedov NF (2013). Neuroscience and Medicine. DOI

Physiological Effects of Selank and Its Fragments

Koroleva SV, Mjasoedov NF (2019). Biology Bulletin. DOI

Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo

Inozemtseva LS, Karpenko EA, Dolotov OV, et al. (2008). Doklady Biological Sciences. PubMed 18841804

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission

Volkova A, Shadrina MI, Kolomin TA, et al. (2016). Frontiers in Pharmacology. PubMed 26924987

For laboratory research use only (in vitro). Not for human or animal use.

Research Use Certification

This website supplies laboratory reference materials intended solely for in vitro research purposes. By entering, you confirm: